Clinical trial
Efficacy of SR121463B in Patients With Syndrome of Inappropriate Antidiuretic…
NCT00032734 · Sanofi, Industry · Completed
Key facts
| NCT number | NCT00032734 |
|---|---|
| Title | Efficacy of SR121463B in Patients With Syndrome of Inappropriate Antidiuretic Hormone Secretion |
| Official title | A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Dose-Escalation, Multicenter Study Evaluating the Efficacy and Safety of SR121463B in Patients With Syndrome of Inappropriate Antidiuretic Hormone Secretion. |
| Lead sponsor | Sanofi, Industry |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Syndrome of Inappropriate ADH (SIADH) Secretion, Hyponatremia |
| Intervention type | Drug |
| Interventions | satavaptan (SR121463B) |
| Enrollment | 35 |
| Start date | Jun 1, 2001 |
| Completion | Jul 1, 2003 |
| First posted | Apr 1, 2002 |
| Last update posted | Jun 17, 2008 |
| Countries | Belgium, France, Germany, Hungary |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: